green tick

Questions raised about pivotal rivaroxaban trial

Questions raised about pivotal rivaroxaban trial

The BMJ’s revelation of a faulty measuring device has put regulators in a spin

12 cardio tips for treating crystal meth users

12 cardio tips for treating crystal meth users

The ice epidemic is keeping hospital cardiologists busy

Real-world study looks at bleeding with dabigatran

Real-world study looks at bleeding with dabigatran

Crucially, the NZ researchers have no big pharma conflicts of interest

Aussie-funded study calls for new BP guidelines

Aussie-funded study calls for new BP guidelines

Targets are not low enough for patients at high risk of major CV events

FDA green light for dabigatran antidote

FDA green light for dabigatran antidote

TGA negotiations are also under way, says company spokesperson

view more

WCC blog: secondary prevention is the low hanging fruit

One of the most interesting presentations at the World Congress of Cardiology in Melbourne this week was a talk by Professor Philip Aylward of Adelaide on how far we have come in the treatment of ACS.

CSANZ 2013 blog: For the ticker, timing is everything

While it’s great to attend a conference like CSANZ, the sheer amount of new and interesting information can be almost too much of a good thing.

view more

 Subscribe to the Newsletter


 Breaking medical news
 A daily must-read for doctors
 Delivered to your inbox
Advertisement
Advertisement
Advertisement
My list
  •  
Read Later